CGL
NUVB icon

Clarius Group LLC’s Nuvation Bio NUVB Stock Holding History

Clarius Group LLC’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-19,691
Closed -$26.4K – 490
2023
Q3 		$26.4K Buy
+19,691
New +$32.8K ﹤0.01% 461
2023
Q2 		– Sell
-17,791
Closed -$29.5K – 509
2023
Q1 		$29.5K Buy
+17,791
New +$36.1K ﹤0.01% 506

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Clarius Group LLC's NUVB Position: Q4 2023 in Review

Clarius Group LLC sold out of Nuvation Bio (NUVB) in Q4 2023, closing a stake of 19,691 shares — an estimated $26.4K sold.

Clarius Group LLC first reported a position in NUVB in Q1 2023 and held it in 2 quarters. The position peaked at $29.5K in Q1 2023. 116 funds tracked by Wall St. Rank hold NUVB as of Q4 2023.

  • Clarius Group LLC reported no remaining Nuvation Bio position as of Q4 2023 after selling out during the quarter.
  • Clarius Group LLC sold 19,691 Nuvation Bio shares in Q4 2023, an estimated $26.4K.
  • Clarius Group LLC first reported a position in Nuvation Bio in Q1 2023 and held it in 2 quarters.
  • Clarius Group LLC's Nuvation Bio position peaked at $29.5K in Q1 2023.
  • 116 funds tracked by Wall St. Rank held Nuvation Bio as of Q4 2023.

Based on Clarius Group LLC's 13F filing for Q4 2023, filed 29 Jan 2024.